Glen Kashuba

Chief Executive Officer at Cerapedics Inc

Glen Kashuba's Professional Contact Details

Email (Verified)

****@cerapedics.com

Get Email Address

(303) 974-6275

Location

New York, New York, US

Company

Cerapedics Inc

Person Seniority

c_suite

Glen Kashuba's Current Company Details

Cerapedics Inc

Westminster, Colorado, US • 19 Employees

biotechnology

Cerapedics is an advanced orthobiologics company focused on developing its proprietary biomimetic small peptide molecule (P-15) for commercialization in spinal applications. i-FACTORâ„¢ Peptide Enhanced Bone Graft (P-15/ABM) is only the 2nd FDA PMA Approve bone graft on the market, and it has shown statistical superiority to local autograft through an IDE trial on single-level ACDFs in overall clinical success at one year. i-FACTORâ„¢ is the only biologic bone graft in orthopedics that incorporates a small peptide as an attachment factor to stimulate the natural bone healing process. This novel mechanism of action (Attract, Attach, Activate) is designed to support safer and more predictable bone formation compared to other commercially available bone growth factors.

Founded Year

2001

Organization Website

cerapedics.com

Organization Languages

English

Organization Revenue

2200

Current Technologies

wordpress org

bootstrap framework

microsoft-iis